PRISM-NK CAR-NK Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRISM-NK CAR-NK Cells, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced Solid Tumors [Phase 1, Phase 2]